Jade Biosciences, Inc. (JBIO) vs SL Science Holding Ltd (SLBT)
A side-by-side comparison of Jade Biosciences, Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JBIO
Jade Biosciences, Inc.
$13.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLBT
SL Science Holding Ltd
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — JBIO vs SLBT
growth of $100 · dividends reinvested · last 1yJBIO -39.8% (-39.8%/yr)SLBT -79.6% (-79.6%/yr)JBIO compounded faster over this window
JBIO SLBT
JBIO vs SLBT: by the numbers
- •SLBT is the larger company ($852M vs $816M market cap).
- •Both run net losses; JBIO's is the smaller (0.00% vs -173.85% net margin).
Metrics side by side
Valuation
| Metric | JBIO | SLBT |
|---|---|---|
| P/B ratio | 1.86 | 373.20 |
Profitability
| Metric | JBIO | SLBT |
|---|---|---|
| Gross margin | 0.00% | 35.27% |
| Operating margin | 0.00% | -174.65% |
| Net margin | 0.00% | -173.85% |
| ROE | -34.83% | -167.25% |
| ROIC | -37.39% | -163.39% |
Growth (annualized)
| Metric | JBIO | SLBT |
|---|---|---|
| Total return CAGR (5Y) | -52.65% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.